Nolvadex and Adenomyosis - a phase IV clinical study of FDA data

Summary:

Adenomyosis is reported as a side effect among people who take Nolvadex (tamoxifen citrate), especially for people who are female, 40-49 old, have been taking the drug for 1 - 2 years also take Arimidex, and have Depression.

The phase IV clinical study analyzes which people have Adenomyosis when taking Nolvadex. It is created by eHealthMe based on reports of 5,421 people who have side effects when taking Nolvadex from the FDA, and is updated regularly.

What is Nolvadex?

Nolvadex has active ingredients of tamoxifen citrate. It is often used in breast cancer. eHealthMe is studying from 5,506 Nolvadex users. Check the latest studies of Nolvadex.

What is Adenomyosis?

Adenomyosis (presence of ectopic glandular tissue found in muscle) is found to be associated with 150 drugs and 257 conditions by eHealthMe. Check the latest studies of Adenomyosis.

On Jul, 20, 2026

5,421 people reported to have side effects when taking Nolvadex.
Among them, 13 people (0.24%) have Adenomyosis.

Among these 13 people:

How long have people been on Nolvadex when they have Adenomyosis? *

What is the gender of people who have Adenomyosis when taking Nolvadex? *

female: 100 %
male: 0.0 %

What is the age of people who have Adenomyosis when taking Nolvadex? *

What are other drugs people take besides Nolvadex? *

Arimidex: 5 people, 38.46%
Zoladex: 3 people, 23.08%
Aspirin: 2 people, 15.38%

What are other side effects people have besides Adenomyosis? *

Vaginal Bleeding Between Periods: 5 people, 38.46%
Uterine Polyp (a mass in the inner lining of the uterus): 3 people, 23.08%
Uterine Leiomyoma (uterine benign tumour derived from smooth muscle): 3 people, 23.08%
Smear Cervix Abnormal: 2 people, 15.38%
Ovarian Cysts (fluid filled sacs of the ovary): 2 people, 15.38%
Heavy Or Prolong Menstrual Bleeding: 2 people, 15.38%
Endometrial Hyperplasia (enlargement of uterus wall): 2 people, 15.38%
Sarcoma Uterus (type of tumour of uterus cancer): 1 person, 7.69%
Post Procedural Haemorrhage (post procedural bleeding): 1 person, 7.69%
Pelvic Inflammatory Disease (Pid): 1 person, 7.69%

What are the existing conditions these people have? *

Depression: 2 people, 15.38%
High Blood Pressure: 1 person, 7.69%

* Approximation only. Some reports may have incomplete information.

Do you take Nolvadex and have Adenomyosis?

- Check whether Adenomyosis is associated with a drug or a condition
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously

Related studies:

Effectiveness of, long term effects of, and alternative drugs to Nolvadex:

Nolvadex (5,506 reports)

Adenomyosis treatments and more:

Adenomyosis (1,214 reports)

Browse all side effects of Nolvadex:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all the drugs that are associated with Adenomyosis:

Adenomyosis (150 drugs)

Browse all the conditions that are associated with Adenomyosis:

Adenomyosis (257 conditions)

Related publications that referenced our studies

K?rm?z?bekmez H, Yesiltepe Mutlu RG, Dursun F, ??güven ?P, "Tamoxifen-associated hirsutism: an unusual side effect in a 5-year-old girl with McCune-Albright syndrome", Journal of Pediatric Endocrinology and Metabolism, 2015 Sep .
K?rm?z?bekmez H, Yesiltepe Mutlu RG, Dursun F, ??güven ?P, "Tamoxifen-associated hirsutism: an unusual side effect in a 5-year-old girl with McCune-Albright syndrome", Journal of Pediatric Endocrinology and Metabolism, 2015 Sep .

How the study uses the data?

The study uses data from the FDA. It is based on tamoxifen citrate (the active ingredients of Nolvadex) and Nolvadex (the brand name). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.